Sylvain Nguyen

Has grant

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Deciphering the LSD1-mediated metabolic reprogramming in cancer cells

Open Date: 2023-12-01

Close Date: 2025-11-30

Grant: Close

Deciphering the neoantigen landscape in bladder cancer patients

Open Date: 2018-03-01

Close Date: 2022-02-28

Articles (8)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Nemo Koi Ikonen

University of Helsinki

FINLAND

View details

LANA E. KANDALAFT

Associate Professor

University of Lausanne

SWITZERLAND

View details

Mathieu Chevalier

Assistant Professor

FRANCE

View details

Philipp Sergeev

University of Helsinki

FINLAND

View details

Beat Roth

Lausanne University Hospital

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sylvain Nguyen

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments

Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile

Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.

Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.

Fibroblast‐derived IL‐33 is dispensable for lymph node homeostasis but critical for CD8 T‐cell responses to acute and chronic viral infection

Collaborators (5)

Nemo Koi Ikonen

LANA E. KANDALAFT

Mathieu Chevalier

Philipp Sergeev

Beat Roth

Make your next move.